CG Oncology (CGON) Other Non-Current Liabilities (2023 - 2026)

CG Oncology's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, changed N/A from the prior year.
• Other Non-Current Liabilities was $1.5 million for Q1 2026 at CG Oncology, down from $1.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.8 million in Q3 2025 and bottomed at $365000.0 in Q4 2023.
• A 3-year average of $1.8 million and a median of $1.6 million in 2025 frame the typical range for Other Non-Current Liabilities.